FindTrial
Sign In

Gepirone vs Placebo in Treatment of Cocaine Dependence - 3

Gepirone vs Placebo in Treatment of Cocaine Dependence

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000189
Enrollment
41
Registered
1999-09-21
Start date
1990-01-31
Completion date
1991-02-28
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

Cocaine Dependence, Gepirone

Brief summary

The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.

Interventions

DRUGGepirone

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026